2011 33 5 0993-0998 http / /xuebao. jxau. edu. cn Acta Agriculturae Universitatis Jiangxiensis E - mail ndxb7775@ sina. com Ara h 2 1 2 3 4 5 6 2 4* 2 4* 1. 518060 2. 518060 3. 830000 4. 518060 5. 518045 6. 518000 Ara h 2 Ara h 2 pet - 32a + Origami Isopropyl β - D - 1 - Thiogalactopyranoside IPTG Ni2 + Western blotting ELISA pet - 32a + SDS - PAGE Western blotting ELISA Ara h 2 F - Ara h 2 Ara h 2 R - Ara h 2 IgE Ara h 2 Ara h 2 Q786 A 1000-2286 2011 05-0993 - 06 Preparation and Characterization of the Genetically Engineered Hypoallergenic Derivative of the Major Peanut Allergen Ara h 2 YI Hai-tao 1 2 LIU Fang 3 JIA Meng-yang 4 TANG Mu-jing 5 CAO Xiao-yong 6 XIA Li-xin 2 4* LIU Zhi-gang 2 4* 1. College of Life Science Shenzhen University Shenzhen 518060 China 2. Institute of Allergy and Immunology Shenzhen University Shenzhen 518060 China 3. Xinjiang Huashidan Pharmaceutical Co. Ltd Wulumuqi 830000 China 4. Medical College Shenzhen University Shenzhen 518060 China 5. Shenzhen Entry - Exit Inspection and Quarantine Bureau Shenzhen 518045 China 6. Maternal and Child Health Hospital of Futian Shenzhen 518000 China Abstract The genetically engineered major allergen Ara h 2 was expressed and purified and the hypoallergenic of purified recombinant F - Ara h 2 protein was characterized. The Ara h 2 was reassembled and inserted into the expression vector pet - 32a +. The vector was transformed into Origami and the protein expression was induced by IPTG. Ni 2 + Chelating affinity chromatography was used to purify the recombinant F - 2011-04 - 18 2011-06 - 14 30871752 SZ2008105 200904 1984 E - mail yihaitao1022@ 163. com * E - mail lzg@ szu. edu. cn E - mail xialixin@ 126. com
994 33 Ara h 2 protein. The hypoallergenic of F - Ara h 2 was examined by Western blotting and ELISA. The ORF which contained 471 bp and encoded 157 amino acids was authenticated to be F - Ara h 2. The recombinant F - Ara h 2 protein induced by IPTG was consistent with the actual value. The affinity between recombinant F - Ara h 2 protein and IgE antibodies from pooled peanut - allergic patients serum was significantly decreased compared with R - Ara h 2 was identified by Western blotting and ELISA. Recombinant F - Ara h 2 protein was hypoallergenic. Key words genetic engineering peanut allergen Ara h 2 hypoallergenic 1-3 2007 3. 9% 1997 2007 18% 4 5 1998 WHO SIT 6 7 8 Ara h 2 IgE F - Ara h 2 1 1. 1 1. 1. 1 8 E. coli Top10 Origami 1. 1. 2 Gel Extraction Kit 50 D2500-01 Plasmid Mini KitⅠ 100 D6943-01 OMEGA EcoRⅠ HindⅢ T4 DNA pet - 32a + DL2 000 DNA Marker TaKaRa Marker SM0671 Fermentas MBI IgE HRP IgE KPL DAB Invitrogen 1. 2 1. 2. 1 Ara h 2 3 IgE 27-36 59-64 65-72 9 3 69-157 62-68 32-61 1-31 1 EcoRⅠ gaattc HindⅢ aagctt g ggg 1. 2. 2 puc57 simple vector F - Ara h 2 F - Ara h 2 puc57 simple vector EcoRⅠ HindⅢ F - Ara h 2 1. 2. 3 pet - 32a + F - Ara h 2 puc57 simple vector F - Ara h 2 F - Ara h 2 pet - 32a + EcoRⅠ HindⅢ T4DNA E. coli Top10 1. 2. 4 pet - 32a + F - Ara h 2 Origami pet - 32a + F - Ara h 2 Origami IPTG 20 mmol /LTris - HCl ph 8. 0 SDS - PAGE 1. 2. 5 F - Ara h 2 SDS - PAGE Ni 2 + 40 mmol /L 100 mmol /L 300 mmol /L
5 Ara h 2 995 SDS - PAGE 1. 2. 6 Western blotting F - Ara h 2 Marker R - Ara h 2 F - Ara h 2 SDS - PAGE F - Ara h 2 R - Ara h 2 2 μg 300 ma SDS - PAGE 8 HRP IgE DAB 1. 2. 7 ELISA F - Ara h 2 A1 - D3 12 100 ng F - Ara h 2 100 μl A4 - D6 200 ng F - Ara h 2 A7 - D9 400 ng F - Ara h 2 A9 - D12 800 ng F - Ara h 2 96 E1 - H3 100 ng R - Ara h 2 100 μl E4 - H6 200 ng R - Ara h 2 E7 - H9 400 ng R - Ara h 2 E9 - H12 800 ng R - Ara h 2 4 2 PBST 3 5 min / 100 μl2% PBST - BSA37 2 h IgE 1 20 37 1 h PBST 3 5 min / Ara h 2 Original Ara h 2 F - Ara h 2 = = IgE IgE 1 Ara h 2 Original represents the original amino acid sequence of Ara h 2 F - Ara h 2 represents 2 000 37 the amino acid sequence of Ara h 2 which is reformed by genetic engineering = = represents 1 h the major IgE epitope of Ara h 2. 1 F - Ara h 2 R - Ara h 2 Fig. 1 Amino acid sequence alignment between F - Ara h 2 and R - Ara h 2 37 1 h TMB 37 30 min 2 mol /L 450 nm SPSS 4 F - Ara h 2 R - Ara h 2 12 2 2. 1 Ara h 2 F - Ara h 2 Ara h 2 BioEdit F - Ara h 2 R - Ara h 2 1 2. 2 puc57 simple vector F - Ara h 2 2 puc57 simple vector F - Ara h 2 EcoRⅠ HindⅢ F - Ara h 2 2. 3 pet - 32a + F - Ara h 2 EcoRⅠ THindⅢ pet - 32a + F - Ara h 2 471 bp 3 2. 4 pet - 32a + F - Ara h 2 SDS - PAGE pet - 32a + F - Ara h 2 Origami
996 33 M DNA Marker DL 2 000 1 puc57 simple vector F - Ara h 2 M DNA Marker DL 2 000 1 Recombinant plasmid puc57 simple vector - F - Ara h 2 digested by restriction enzymes. 2 puc57 simple vector - F - Ara h 2 EcoRⅠ HindⅢ Fig. 2 puc57 simple vector - F - Ara h 2 digested by restriction enzymes EcoRⅠand HindⅢ M DNA Marker DL 2 000 1 pet - 32a + F - Ara h 2 M DNA Marker DL2 000 1 Recombinant plasmid pet - 32a + - F - Ara h 2 digested by restriction enzymes. 3 pet - 32a + F - Ara h 2 EcoRⅠ HindⅢ Fig. 3 Restriction enzymes digestion analysis of recombinant plasmid pet - 32a + - F - Ara h 2 SDS - PAGE 40 mmol /L 100 mmol /L 300 mmol /L F - Ara h 2 300 mmol /L Marker 300 mmol /L SDS - PAGE 4 4 37 kda pet - 32a + N 6 His - Tag 20 kda F - Ara h 2 17 kda 2. 5 Western blotting F - Ara h 2 Western blotting R - Ara h 2 37kDa F - Ara h 2 37 kda R - Ara h 2 ELISA R - Fig. 4 Ara h 2 F - Ara h 2 M Marker 1 pet - 32a + F - Ara h 2 Origami F - Ara h 2 2 3 4 R - Ara h 2 5 F - Ara h 2 IgE M Protein marker 1 E. coli Origami /pet -32a - F - Ara h 2 before induction 5 2. 6 ELISA F - Ara h 2 2 E. coli Origami /pet - 32a + - F - Ara h 2 after induction by IPTG for 4 h 3 The supernatant of ultrasound 4 The precipitation of ultrasound 5 The recombinant F - Ara h 2 purified by affinity chromatography. 4 F - Ara h 2 Expression and purification of recombinant F - Ara h 2 protein
5 Ara h 2 997 4 SPSS P < 0. 001 R - Ara h 2 F - Ara h 2 F - Ara h 2 IgE R - Ara h 2 6 3 10 40 10 M Marker 1 Ara h 2 R - Ara h 2 2 Ara h 2 F - Ara h 2 IgE I M Protein marker 1 R - Ara h 2 2 F - Ara h 2. 11 5 F - Ara h 2 12-13 Fig. 5 Western blotting analysis of recombinant F - Ara h 2 protein 14 15-17 R - Ara h 2 Ara h 2 F - Ara h 2 Ara h 2 *** P < 0. 001 R - Ara h 2 F - Ara h 2 18-19 R - Ara h 2 represents recombinant Ara h 2 protein F - Ara h 2 represents genetically engineered Ara h 2 protein *** P <0. 001 represents the difference between R - Ara h 2 and F - Ara h 2 is Extremely significant. 6 F - Ara h 2 ELISA Ara h 2 Fig. 6 ELISA analysis of recombinant F - Ara h 2 protein IgE T Ara h 2 3 IgE 27-36 59-64 65-72 T 3 IgE 69-157 62-68 32-61 1-31 Western - blotting ELISA F - Ara h 2 IgE R - Ara h 2 R - Ara h 2
998 33 1 Kim E H Bird J A Kulis M et al. Sublingual immunotherapy for peanut allergy Clinical and immunologic evidence of desensitization J. J Allergy Clin Immunol 2011 127 3 640-646. 2. J. 2010 34 6 567-571. 3. α - J. 2010 34 3 244-248. 4 Branum A M Lukacs S L. Food allergy among U S. children trends in prevalence and hospitalization J. NCHS Data Brief 2008 10 10 1-8. 5 Sicherer S H Munoz - Furlong A Godbold J H et al. US prevalence of selfreported peanut tree nut and sesame allergy 11 - year follow - up J. J Allergy Clin Immunol 2010 125 6 1322-1326. 6 Larche M Akdis C A Valenta R. Immunological mechanisms of allergen - specific immunotherapy J. Nat Rev Immunol 2006 6 1 761-771. 7 Oppenheimer J J Nelson H S Bock S A et al. Treatment of peanut allergy with rush immunotherapy J. J Allergy Clin Immunol 1992 90 2 256-262. 8 Bannon G A Shin D Maleki S et al. Tertiary structure and biophysical properties of a major peanut allergen implications for the production of a hypoallergenic protein J. Int Arch Allergy Immunol 1999 118 2-4 315-316. 9. Ara h 2 Ara h 6 J. 2010 27 2 241-245. 10. 40 J. 1986 12 6 12-13. 11. IgE J. 2006 29 3 236-238. 12 Fecek R J Marcondes Rezende M Busch R et al. Enteric reovirus infection stimulates peanut - specific IgG2a responses in a mouse food allergy model J. Immunobiology 2010 215 12 941-948. 13. Ara h 2. 02 J. 2010 34 5 531-535. 14 Hefle S L Furlong T J Niemann L et al. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts J. J Allergy Clin Immunol 2007 120 1 171-176. 15 Thalhamer T Dobias H Stepanoska T et al. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening J. J Allergy Clin Immunol 2010 125 4 926-934. 16 Bousquet J Lockey R Malling H J et al. Allergen immunotherapy therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy Asthma and Immunology J. Ann Allergy Asthma Immunol 1998 81 5 401-405. 17 Valenta R. The future of antigen - specific immunotherapy of allergy J. Nat Rev Immunol 2002 2 6 446-453. 18 Ferreira F Wallner M Thalhamer J. Customized antigens for desensitizing allergic patients J. Adv Immunol 2004 84 79-129. 19 Jutel M Jaeger L Suck R et al. Allergen - specific immunotherapy with recombinant grass pollen allergens J. J Allergy Clin Immunol 2005 116 3 608-613.